Haemato AG Capital Reinvestment Ratio
Haemato AG capital reinvestment ratio. Haemato AG (HAEK) has a Capital Reinvestment Ratio of 0.06x as of December 2022, meaning it reinvests 0% of its operating cash flow (€19.73 Million) in capital expenditures (€1.09 Million). Check how aggressively does Haemato AG reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Haemato AG (2021–2022)
Capital reinvestment ratio of Haemato AG from 2021 to 2022. This chart tracks Haemato AG's Capital Reinvestment Ratio across 2 annual periods. Also explore HAEK net assets growth trend to track the company's year-over-year net asset growth rate.
Haemato AG Capital Reinvestment Ratio by Year (2021–2022)
Haemato AG capital reinvestment ratio by year from 2021 to 2022. For the full cash flow conversion analysis, see Haemato AG (HAEK) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.06x | €19.73 Million | €1.09 Million | ▲ +137.4% |
| 2021 | 0.02x | €14.05 Million | €326.75K | — |